Hart CM

Language: Spanish
References: 9
Page: 1-6
PDF size: 213.21 Kb.

ABSTRACT

Introduction: The disease caused by the new coronavirus constitutes a challenge for health systems. In these times of pandemic, having tests that help early diagnosis and even detect asymptomatic patients is one of the keys to reducing infections and preventing the spread. Objective: To review the most important aspects in the diagnosis of the new coronavirus. Findings: Detection of SARS-CoV2 RNA in respiratory samples is the reference and technique of choice for the microbiological diagnosis of COVID-19. By taking samples from the back of the pharynx and the nostrils, the presence of the virus can be detected. Antigen detection is a type of rapid diagnostic test which detects the presence of viral proteins (antigens) expressed by COVID-19 virus. Detection of the antibodies generated in the infected host organism is one of the most widely used techniques worldwide in large populations, even as screening, although its interpretation may require the intervention of specialists. It is also based on the detection of IgM and IgG type antibodies and some have the detection of IgA antibodies. Conclusions: The interpretation of serological tests should be done with caution, taking into account the limitations, and assessing them according to the patient's clinical situation and the results of the reference test.

REFERENCES

1. Eiros JM, Ortiz de Lejarazu R, Tenorio A, Casas I, Pozo F, Ruiz G, Pérez Breña P. Diagnóstico microbiológico de las infecciones virales respiratorias. Enferm Infecc Microbiol Clin. 2009;27(3):168-77.

2. To KK W, Tsang OT Y, Leung WS, Tam AR, Wu T-C, Lung DC, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565-74.

3. World Health Organization. Coronavirus disease 2019 (COVID-19). Situation report – 73. 2020. Disponible en: https://www.who.int/docs/default- source/coronaviruses/situation - reports/20200402- sitrep-73 covid -19.pdf

4. Zhang XY, Huang HJ, Zhuang DL, Nasser MI, Yang MH, Zhu P, et al. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2. Infect Dis Poverty. 2020;9(1):99. Doi: https://doi.org/10.1186/s40249- 020-00691-6

5. David P, Shoenfeld Y. The Smell in COVID-19 Infection: Diagnostic Opportunities. Isr Med Assoc J. 2020;7(22):335-37.

6. Wong CK, Ho DTY, Tam AR, Zhou M, Lau YM, Tang MOY, et al. Artificial intelligence mobile health platform for early detection of COVID-19 in quarantine subjects using a wearable biosensor: protocol for a randomised controlled trial. BMJ. 2020;10(7):e038555. Doi: https://doi.org/10.1136/bmjopen-2020-038555

7. Velázquez Pérez L. La COVID-19: reto para la ciencia mundial. Anales de la Academia de Ciencias de Cuba. 2020[acceso: 07/05/2020];10(2). Disponible en: http://www.revistaccuba.cu/index.php/revacc/article/view/763

8. Biggs HM, Harris JB, Breakwell L, Dahlgren FS, Abedi GR, Szablewski CM, et al. Estimated Community Seroprevalence of SARS-CoV-2 Antibodies-Two Georgia Counties, MMWR Morb Mortal Wkly Rep. 2020;69(29):965-70. Doi: https://doi.org/10.15585/mmwr.mm6929e2

9. Hasan MR, Mirza F, Al-Hail H, Sundararaju S, Xaba T, Iqbal M, et al. Detection of SARS-CoV-2 RNA by direct RT-qPCR on nasopharyngeal specimens without extraction of viral RNA. PLoS One. 2020;15(7):e0236564. Doi: https://doi.org/10.1371/journal.pone.0236564